Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation

Biochem Biophys Res Commun. 2008 Dec 19;377(3):826-31. doi: 10.1016/j.bbrc.2008.10.077. Epub 2008 Oct 23.

Abstract

The close association of inflammation, angiogenesis and cancer progression is now highlighted, and in this study we especially focused on a close association of inflammation and lymphangiogenesis. We found that proinflammatory cytokine, interleukin-1beta (IL-1beta), could induce lymphangiogenesis in mouse cornea through enhanced production of potent lymphangiogenic factors, VEGF-A, VEGF-C and VEGF-D. IL-1beta-induced lymphangiogenesis, but not angiogenesis, was inhibited by administration of a selective anti-VEGF receptor-3 (VEGFR-3) neutralizing antibody. And in mouse cornea we observed recruitment of monocyte/macrophages and neutrophils by IL-1beta implanted cornea. Depletion of macrophages by a bisphosphonate encapsulated in liposomes inhibited this IL-1beta-induced lymphangiogenesis and also up-regulation of VEGF-A, VEGF-C, and VEGF-D. Furthermore, IL-1beta-induced lymphangiogenesis and angiogenesis were suppressed by NF-kappaB inhibition with marked suppression of VEGF-A, VEGF-C, and VEGF-D expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • Cornea / blood supply
  • Cornea / drug effects
  • Cornea / immunology
  • Diphosphonates / pharmacology
  • Fibroblast Growth Factor 2 / biosynthesis
  • Fibroblast Growth Factor 2 / genetics
  • Fibroblast Growth Factor 2 / pharmacology
  • Humans
  • Interleukin-1beta / immunology*
  • Interleukin-1beta / pharmacology
  • Keratitis / immunology*
  • Lymphangiogenesis / drug effects
  • Lymphangiogenesis / genetics
  • Lymphangiogenesis / immunology*
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B / agonists
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism*
  • Neovascularization, Pathologic / immunology
  • Vascular Endothelial Growth Factor C / biosynthesis*
  • Vascular Endothelial Growth Factor C / genetics
  • Vascular Endothelial Growth Factor C / pharmacology
  • Vascular Endothelial Growth Factor D / biosynthesis*
  • Vascular Endothelial Growth Factor D / genetics
  • Vascular Endothelial Growth Factor D / pharmacology

Substances

  • Diphosphonates
  • Interleukin-1beta
  • NF-kappa B
  • Vascular Endothelial Growth Factor C
  • Vascular Endothelial Growth Factor D
  • Fibroblast Growth Factor 2